Caregiver Burden, Caregiver Stress Syndrome
Conditions
Brief summary
This study aims to pilot test a culturally tailored behavioral intervention called "WECARE" to enhance caregiving mastery and improve psychosocial wellbeing of Chinese American family caregivers of persons with Alzheimer's Disease and related dementia.
Detailed description
The investigators propose to test a culturally tailored mHealth behavioral intervention to enhance caregiving mastery and improve psychosocial wellbeing among Chinese American family caregivers of persons living with Alzheimer's Disease and related dementia. This intervention, Wellness Enhancement for Caregivers (WECARE), will be delivered via WeChat, a social media app highly popular among Chinese Americans. About 45 participants will be recruited for the pilot test. Participants will complete a baseline survey, receive 7-week WECARE program on their WeChat accounts, complete a follow-up survey 12 weeks after the baseline, and then a qualitative interview on Zoom.
Interventions
BEHAVIORALWellness Enhancement for Caregivers (WECARE)
WECARE behavioral intervention is guided by behavioral theories aimed to increase participants' caregiving mastery, enhance self-care, and improve psychosocial wellbeing. Participants will receive multimedia content on their WeChat account on cellphone or tablet, including short video clips, pictorial messages, short articles, and audio recordings 6 days a week, for 7 weeks.
Sponsors
George Mason University
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
21 Years to 90 Years
Healthy volunteers
Yes
Inclusion criteria
1. 21 years or older, 2. self-identified as Chinese or Chinese American, 3. speak and read Chinese (Mandarin or Cantonese), 4. own a smartphone and use WeChat, 5. living in Washington DC metropolitan, and 6. currently care for a family member with ADRD and provide care for at least 10 hours a week.
Exclusion criteria
1. do not read or speak Chinese, 2. care-recipient is in hospice care or have a life expectancy less than 6 months, 3. signs of severe intellectual deficits or psychotic disorders, or 4. unable to provide informed consent.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Efficacy of Behavioral Intervention in Change From Baseline in Depressive Symptoms | Baseline, and Follow-Up at Weeks 11-12 (4 to 5 weeks after completion of the intervention) | The baseline and follow-up differences in depressive symptoms will be assessed using the Center for Epidemiologic Studies Depression Scale (CES-D). The CES-D is a 20-item survey instrument designed to measure the frequency and severity of depressive symptoms. The total score is calculated by summing the responses to all 20 items. The total scale ranges from 0 to 60, with higher scores indicating more severe depressive symptoms (a worse outcome). The primary analysis will calculate the difference in this total score between baseline and follow-up. adults and dementia caregivers. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Efficacy of Behavioral Intervention in Change From Baseline in Caregiving Burden | Baseline, and Follow-Up at Weeks 11-12 (4 to 5 weeks after completion of the intervention) | The baseline and follow-up differences in caregiving burden will be assessed using the 12-item Zarit Burden Interview (ZBI-12). The ZBI-12 is designed to measure the subjective physical, psychological, and social burden experienced by caregivers. Each item is rated on a 5-point scale from "never" (0) to "nearly always" (4), The total score is calculated by summing the responses to all 12 items. The total scale ranges from 0 to 48, with higher scores indicating greater caregiving burden (a worse outcome). The primary analysis will calculate the difference in this total score between baseline and follow-up. |
| Efficacy of Behavioral Intervention in Change From Baseline in Life Satisfaction | Baseline, and Follow-Up at Weeks 11-12 (4 to 5 weeks after completion of the intervention) | The baseline and follow-up differences in life satisfaction will be assessed using the Satisfaction with Life Scale (SWLS). The SWLS is a 5-item survey instrument designed to measure a person's global cognitive judgments of satisfaction with their life. The total score is calculated by summing the responses to all 5 items. The total scale ranges from 0 to 30, with higher scores indicating greater life satisfaction (a better outcome). The primary analysis will calculate the difference in this total score between baseline and follow-up. |
Countries
United States
Contacts
PRINCIPAL_INVESTIGATORAlicia Hong
George Mason University
Participant flow
Recruitment details
Some articipants are recruited through the UCSF CARE registry. Most participants are recruited through with our community partners located in Washington DC and New York. Recruitment flyers will be sent to communities via social media outlets or e-newsletters. Eligibility for study participation will be determined through telephone screenings conducted by trained research personnel.
Baseline characteristics
| Characteristic | — |
|---|---|
| Age, Categorical <=18 years | 0 Participants |
| Age, Categorical >=65 years | 22 Participants |
| Age, Categorical Between 18 and 65 years | 26 Participants |
| Age, Continuous | 64 Years STANDARD_DEVIATION 12 |
| Ethnicity (NIH/OMB) Hispanic or Latino | 0 Participants |
| Ethnicity (NIH/OMB) Not Hispanic or Latino | 48 Participants |
| Ethnicity (NIH/OMB) Unknown or Not Reported | 0 Participants |
| Race (NIH/OMB) American Indian or Alaska Native | 0 Participants |
| Race (NIH/OMB) Asian | 48 Participants |
| Race (NIH/OMB) Black or African American | 0 Participants |
| Race (NIH/OMB) More than one race | 0 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 0 Participants |
| Race (NIH/OMB) White | 0 Participants |
| Region of Enrollment United States | 48 participants |
| Sex: Female, Male Female | 43 Participants |
| Sex: Female, Male Male | 5 Participants |
Adverse events
| Event type | EG000 affected / at risk |
|---|---|
| deaths Total, all-cause mortality | 0 / 48 |
| other Total, other adverse events | 0 / 48 |
| serious Total, serious adverse events | 0 / 48 |
Outcome results
None listed